BioSpace News Archive

Data were featured in an oral presentation at the IASLC 19th World Conference on Lung Cancer.

OSF Ventures, the corporate investment arm of OSF HealthCare, was part of an investor syndicate helping medtech company, Endotronix, Inc., close a $45 million Series D round of financing.

Equipped with knowledge and backed by rich industry experience, British Biologicals, an award-winning global nutraceutical company, has announced Bharath Reddy, Director of International Business Development and Operations, will lead the company’s expansion into the United States for an end-to-end solution for the nutritional supplement industry.

At its 2018 awards gala, BioAlberta, the province’s life sciences industry association, recognized two leaders for their innovation and achievements. BioAlberta congratulates Circle Cardiovascular Imaging Inc. for winning its Company of the Year award and Dr. John Lewis for winning its Scientific Achievement and Innovation Award.

myvacTM is a viral vector-based, individualized immunotherapy that has been developed to target solid tumors.

The Hazelden Betty Ford Foundation today welcomed the Oklahoma State University Addiction Medicine Clinic as the newest member of its expanding Patient Care Network.

Grifols is pleased to announce the opening of its newest Biotest Pharmaceuticals Corporation plasma donor center located at 1616 East Wooster Street, Bowling Green, Ohio.

The Food and Drug Administration (FDA) today announced that it has awarded 12 new clinical trial research grants totaling more than $18 million over the next four years to enhance the development of medical products for patients with rare diseases.

New food allergy diagnostics company, AllerGenis, LLC., recently launched for the purpose of bringing innovative, precision diagnostic solutions to food allergy clinicians, with the goal of improving patient outcomes through highly accurate and safe diagnostic tools.

MedX Health Corp. announces the following changes to its Board and Executive team, effective immediately. Scott Spearn, who joined the Company as President in April 2018 is taking on the additional role of Chief Executive Officer and is joining the Board of Directors. Rob von der Porten, previously the CEO, has been appointed as Chairman of the Board in place of Gary Van Nest who has retired from that position and remains as a director.